1-4 of 4
Brayan Merchan, MD MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment

Free
David Roman, MD, Leonor Arenillas, MD PhD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Marta Salido, PhD, Puiggros Anna, Blanca Espinet, PhD, Lluís Colomo, MD PhD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Xavier Calvo, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4262.
https://doi.org/10.1182/blood-2019-128768
Published: 2019
Journal Articles

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Free
Xavier Calvo, MD PhD, Nieves Garcia-Gisbert, MSc, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4266.
https://doi.org/10.1182/blood-2019-130445
Published: 2019
Journal Articles

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Free
Xavier Calvo, MD PhD, Ivonne Parraga, Fellow, Nieves Garcia-Gisbert, MSc, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade Campos, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5437.
https://doi.org/10.1182/blood-2019-130499
Published: 2019
Journal Articles

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

Free
Jorge Sierra, MD, Ana Garrido, Marina Diaz Beya, MD, Montserrat Hoyos, Marisa Calabuig, MD, Susana Vives, MD, Montserrat Arnan Sangerman, MD PhD, Maria Paz Queipo De Llano, MD, Olga Salamero, MD, Ferran Vall-Llovera, MD, Alex Bataller, Francisca Guijarro, MD, Lourdes Escoda, MD, Antonio Garcia-Guiñon, MD, Brayan Merchan, MD MSc, Xavier Ortin, Isabel Sanchez Ortega, MD PhD, Marta Pratcorona, MD PhD, Joan Bargay, MD PhD, Antonia Sampol, Josep Nomdedeu, MD PhD, David Gallardo, Josep-Maria Ribera, MD PhD, Mar Tormo, Jordi Esteve, Salut Brunet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 289.
https://doi.org/10.1182/blood-2019-128682
Published: 2019